Danazol therapy in thrombocytopenia associated with the antiphospholipid antibody syndromeKAVANAUGH, A.Annals of internal medicine. 1994, Vol 121, Num 10, pp 767-768, issn 0003-4819Article

Evolution of anti-TNF treatment for rheumatoid arthritisKAVANAUGH, A.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 3, issn 0392-856X, 41 p., SUP59Serial Issue

ALTERATIONS IN IMMUNE FUNCTION IN RATS CAUSED BY DIETARY LIPOTROPE DEFICIENCY: EFFECT OF AGENAUSS KM; CONNOR AM; KAVANAUGH A et al.1982; JOURNAL OF NUTRITION; ISSN 0022-3166; USA; DA. 1982; VOL. 112; NO 12; PP. 2333-2341; BIBL. 24 REF.Article

A need for greater reporting of socioeconomic status and race in clinical trialsLEE, S. J; KAVANAUGH, A.Annals of the rheumatic diseases. 2004, Vol 63, Num 12, pp 1700-1701, issn 0003-4967, 2 p.Article

Quantitative clinical assessment of rheumatic diseasesKAVANAUGH, A; PINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, issn 0392-856X, 208 p., SUP39Serial Issue

Development of TNF inhibitor therapies for the treatment of rheumatoid arthritisFURST, D. E.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 3, issn 0392-856X, S5-S12, SUP59Article

Impact of dosing on treatment with TNF inhibitors: managing dose adjustmentCOMBE, B.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 3, issn 0392-856X, S13-S17, SUP59Article

HTLV-IGROSS, D. J; KAVANAUGH, A.International journal of dermatology. 1990, Vol 29, Num 3, pp 161-165, issn 0011-9059, 5 p.Article

Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for near remission of DAS or single measuresPINCUS, T; SOKKA, T; KAVANAUGH, A et al.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 5, pp 50-56, issn 0392-856X, 7 p., SUP35Article

Psoriatic arthritis: treat-to-targetKAVANAUGH, A.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S123-S125, SUP73Article

Defining remission in psoriatic arthritisKAVANAUGH, A; FRANSEN, J.Clinical and experimental rheumatology (Testo stampato). 2006, Vol 24, Num 6, issn 0392-856X, S83-S87, SUP43Article

The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis : A systematic reviewRIEDEMANN, J. P; MUNOZ, S; KAVANAUGH, A et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S69-S76, issn 0392-856X, SUP39Article

Benefit/risk of therapies for rheumatoid arthritis: Underestimation of the side effects or risks of RA leads to underestimation of the benefit/risk of therapiesPINCUS, T; KAVANAUGH, A; SOKKA, T et al.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 5, pp 2-11, issn 0392-856X, 10 p., SUP35Article

Critical analysis of economic tools and economic measurement applied to rheumatoid arthritisHER, M; KAVANAUGH, A.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S107-S111, SUP73Article

Tuberculosis and opportunistic infections: Relevance to biologic agentsBIEBER, J; KAVANAUGH, A.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 5, pp 126-133, issn 0392-856X, 8 p., SUP35Article

Assessment of pain in rheumatic diseasesSOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S77-S84, issn 0392-856X, SUP39Article

The American College of Rheumatology (ACR) Core Data set and derivative patient only indices to assess rheumatoid arthritisPINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S109-S113, issn 0392-856X, SUP39Article

A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA) : Efficient capture of essential data for clinical trials and observational studiesPINCUS, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S114-S119, issn 0392-856X, SUP39Article

The Fibromyalgia Impact Questionnaire (FIQ) : a review of its development, current version, operating characteristics and usesBENNETT, R.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S154-S162, issn 0392-856X, SUP39Article

The CORRONA databaseKREMER, J. M.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S172-S177, issn 0392-856X, SUP39Article

Rheumatoid arthritis databases in FinlandSOKKA, T.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S201-S204, issn 0392-856X, SUP39Article

DANBIO : a nationwide registry of biological therapies in DenmarkHETLAND, M. L.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S205-S207, issn 0392-856X, SUP39Article

Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritisKAVANAUGH, A. F.Rheumatic diseases clinics of North America. 1998, Vol 24, Num 3, pp 593-614, issn 0889-857XArticle

Central nervous system angiopathy associated with cocaine abuseMARTIN, K; ROGERS, T; KAVANAUGH, A et al.Journal of rheumatology. 1995, Vol 22, Num 4, pp 780-782, issn 0315-162XArticle

The assessment of disease activity in rheumatoid arthritisSMOLEN, J. S; ALETAHA, D.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 3, issn 0392-856X, S18-S27, SUP59Article